Skip to main content

Publications search

Found 34901 matches. Displaying 61-70
Dunn AD
Show All Authors

Signaling Properties of Structurally Diverse Kappa Opioid Receptor

ACS CHEMICAL NEUROSCIENCE 2019 AUG; 10(8):3590-3600
Biased ligands preferentially activate certain signaling pathways
Hertz NT
Show All Authors

Neuronally Enriched RUFY3 Is Required for Caspase-Mediated Axon

NEURON 2019 AUG 7; 103(3):412-422.e4
Selective synaptic and axonal degeneration are critical aspects of both
Roco JA
Show All Authors

Class-Switch Recombination Occurs Infrequently in Germinal Centers

IMMUNITY 2019 AUG 20; 51(2):337-350.e7
Class-switch recombination (CSR) is a DNA recombination process that
Sabri A
Show All Authors

Prevalence and risk factors for latent tuberculosis infection among

PLOS ONE 2019 AUG 15; 14(8):? Article e0221081
Increased prevalence of latent tuberculosis infection (LTBI) has been
Blackmon K
Show All Authors

Cortical gray-white matter blurring and declarative memory impairment in

EPILEPSY & BEHAVIOR 2019 AUG; 97(?):34-43
Magnetic resonance imaging (MRI)- negative temporal lobe epilepsy (TLE)
Belkaya S
Show All Authors

Inherited IL-18BP deficiency in human fulminant viral hepatitis

JOURNAL OF EXPERIMENTAL MEDICINE 2019 AUG; 216(8):1777-1790
Fulminant viral hepatitis (FVH) is a devastating and unexplained
Huang YC
Show All Authors

Gain-of-function mutations in the UNC-2/CaV2 alpha channel lead to

ELIFE 2019 AUG 5; 8(?):? Article e45905
Mutations in pre-synaptic voltage-gated calcium channels can lead to
Lopez-Hernandez I
Show All Authors

Skewed X-inactivation in a Female Carrier with X-linked Chronic

IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY 2019 AUG; 18(4):447-451
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused
Brunner PM, He H, Pavel AB, Czarnowicki T, Lefferdink R, Erickson T, Canter T, Puar N, Rangel SM, Malik K, Estrada Y, Krueger JG, Guttman-Yassky E, Paller AS
Show All Authors

The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2019 AUG; 81(2):510-519
Background: Despite increasing evidence that adults with long-standing atopic dermatitis (AD) have systemic inflammation, little is known about systemic inflammation in recent-onset early pediatric AD. Objective: To analyze blood inflammatory proteins of early pediatric AD. Methods: Using high-throughput proteomics (proximity extension assay), we assessed 257 inflammatory and cardiovascular risk proteins in the blood of 30 children with moderate to severe AD younger than 5 years of age (within 6 months of onset) compared with age-matched pediatric control individuals and adult patients with AD. Results: In pediatric AD blood, T helper (Th) type 2 (CCL13, CCL22) and Th17 (peptidase inhibitor-3/elafin) markers were increased, together with markers of tissue remodeling (matrix metalloproteinases 3/9/10, urokinase receptor), endothelial activation (E-selectin), T-cell activation (IL2RA), neutrophil activation (myeloperoxidase), lipid metabolism (FABP4), and growth factors (FGF21, transforming growth factor-alpha). Total numbers of dysregulated proteins were smaller in pediatric AD (n = 22) than in adult AD (n = 61). Clinical severity scores were positively correlated with receptors for interleukins 33 and 36 and inversely correlated with some Th1 markers (interferon gamma, CXCL11). Limitations: Different baseline expression levels in healthy pediatric vs adult samples. Conclusions: Within months of pediatric AD onset, systemic immune activation is present, with Th2/Th17 skewing but otherwise different proteomic patterns from adult AD. Future correlation of proteomic patterns with disease course, comorbidity development, and drug response may yield predictive biomarkers.
Frew JW
Show All Authors

Assessing the efficacy of new biologic therapies in hidradenitis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2019 AUG; 33(8):E298-E300
Linked article: M. Kovacs et al. J Eur Acad Dermatol Venereol 2019; 33: